drugset / Trial / NCT01010737
A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers
RandomizedParallel-groupSingle-blindPrevention
Summary
This is a phase I/II, randomized, single-blind, placebo-controlled escalating double-dose study of the safety and priming potential of an intramuscular Influenza vaccine (Multimeric-001) injected to elderly volunteers.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Montanide ISA VG51 | Unknown | — | Intramuscular |
| Subject | Multimeric-001 | Vaccine | 250 ug | Intramuscular |
| Subject | Multimeric-001 | Vaccine | 500 ug | Intramuscular |
| Background | Influenza Virus Vaccine | Vaccine | — | — |